rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Matthew Rabinowitz

Executive Chairman

Company insider

Files Form 4 as: Executive Chairman, Natera.

Every Form 4 they filed

In numbers

Trades disclosed
517
Buys
1
Sells
102
Bought
$6.3M
Sold
$417.8M
Companies
1
Companies where not an officer
0
First trade
8 Jul 2015
Last trade
15 Oct 2026
Last filed
16 Oct 2026

Companies traded

Where they are an officer
NTRA NateraDirector, Officer · Diagnostics & Labs · last 15 Oct 20261 buy · 102 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
40Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
15 Oct 2026filed 16 Oct 2026NTRA NateraDiagnostics & LabsSEC FORM 4 Code M$521K50,000 at $10.41filing
15 Oct 2026filed 16 Oct 2026NTRA NateraDiagnostics & LabsSEC FORM 4 Sold$239K600 at $398.09filing
15 Oct 2026filed 16 Oct 2026NTRA NateraDiagnostics & LabsSEC FORM 4 Sold$317K793 at $399.31filing
15 Oct 2026filed 16 Oct 2026NTRA NateraDiagnostics & LabsSEC FORM 4 Sold$1.1M2,671 at $400.31filing
15 Oct 2026filed 16 Oct 2026NTRA NateraDiagnostics & LabsSEC FORM 4 Sold$2.4M5,974 at $401.42filing
15 Oct 2026filed 16 Oct 2026NTRA NateraDiagnostics & LabsSEC FORM 4 Sold$2.5M6,309 at $402.23filing
15 Oct 2026filed 16 Oct 2026NTRA NateraDiagnostics & LabsSEC FORM 4 Sold$1.6M3,858 at $403.27filing
15 Oct 2026filed 16 Oct 2026NTRA NateraDiagnostics & LabsSEC FORM 4 Sold$4.2M10,321 at $404.64filing
15 Oct 2026filed 16 Oct 2026NTRA NateraDiagnostics & LabsSEC FORM 4 Sold$2.5M6,274 at $405.18filing
15 Oct 2026filed 16 Oct 2026NTRA NateraDiagnostics & LabsSEC FORM 4 Sold$569K1,400 at $406.63filing
15 Oct 2026filed 16 Oct 2026NTRA NateraDiagnostics & LabsSEC FORM 4 Sold$1.5M3,800 at $407.27filing
15 Oct 2026filed 16 Oct 2026NTRA NateraDiagnostics & LabsSEC FORM 4 Sold$111K286 at $388.32filing
15 Oct 2026filed 16 Oct 2026NTRA NateraDiagnostics & LabsSEC FORM 4 Sold$816K2,000 at $408.24filing
15 Oct 2026filed 16 Oct 2026NTRA Nateraoption or derivative · Diagnostics & LabsSEC FORM 4 Code M—50,000 at $0.00filing
15 Oct 2026filed 16 Oct 2026NTRA NateraDiagnostics & LabsSEC FORM 4 Sold$278K714 at $389.84filing
15 Oct 2026filed 16 Oct 2026NTRA NateraDiagnostics & LabsSEC FORM 4 Sold$234K600 at $390.21filing
15 Oct 2026filed 16 Oct 2026NTRA NateraDiagnostics & LabsSEC FORM 4 Sold$117K300 at $391.58filing
15 Oct 2026filed 16 Oct 2026NTRA NateraDiagnostics & LabsSEC FORM 4 Sold$315K800 at $393.47filing
15 Oct 2026filed 16 Oct 2026NTRA NateraDiagnostics & LabsSEC FORM 4 Sold$118K300 at $394.40filing
15 Oct 2026filed 16 Oct 2026NTRA NateraDiagnostics & LabsSEC FORM 4 Sold$753K1,900 at $396.30filing

The newest 500 lines are listed; the numbers count every line.

Sectors

Health Care103

Buys in green, sells in red, by the company’s sector.

Related people

Jonathan SheenaDirector and Other role · Director and Other at Natera, filing Form 4 there in the last year
Solomon MoshkevichPresident, Clinicaldiagnostics · President, Clinicaldiagnostics at Natera, filing Form 4 there in the last year
Steven Leonard ChapmanCEO and President · CEO and President at Natera, filing Form 4 there in the last year
John FeskoPresident, Chief Bus. Officer · President, Chief Bus. Officer at Natera, filing Form 4 there in the last year
Daniel RabinowitzSec. and Chief Legal Officer · Sec. and Chief Legal Officer at Natera, filing Form 4 there in the last year
Michael Burkes BrophyChief Financial Officer · Also traded NTRA in the last 90 days